Home
About
Overview
Sharing Data
ORCID
Help
History (3)
Intermediate-risk Non-muscle-invasive Bladder Cancer: Updated Consensus Definition and Management Recommendations from the International Bladder Cancer Group.
The landscape of androgen deprivation therapies for the treatment of advanced prostate cancer.
Waiting time from initial urological consultation to nephrectomy for renal cell carcinoma--does it affect survival?
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The landscape of androgen deprivation therapies for the treatment of advanced prostate cancer.
The landscape of androgen deprivation therapies for the treatment of advanced prostate cancer. Future Oncol. 2024 Nov 18; 1-4.
View in:
PubMed
authors with profiles
Michael S Cookson